Matrix Laboratories Recieves Tentative FDA Approval To Provide Generic ARV Under PEPFAR Pharmaceutical company Mylan announced on Tuesday that its "subsidiary Matrix Laboratories Ltd. has received tentative government approval for atazanavir sulfate capsules, an AIDS treatment that will be...
Column Examines How Trade Rules, Policy Directions May Improve Access To ARVs In an Intellectual Property Watch column, Daniele Dionisio, of the Italian Network for International Fight against AIDS, examines how trade rules and policy directions by governments and institutions may help...